Pfizer

About

Pfizer is a pharmaceuticals and biotechnology company that supports wellness and prevention

New York,New York,United States
10001 - max
http://www.pfizer.com

Highlights

Details

Last Funding Type: IPO
Industries: Biotechnology,Health Care,Medical,Pharmaceutical
Founded date: Jan 1, 1849
Number Of Employee: 10001 - max
Operating Status: Active
Stock Symbol: nyse:PFE
Legal Name: Pfizer Inc.

Pfizer provides access to safe and effective and affordable medicines and health care services. They have a portfolio of products and medicines that support wellness and prevention, as well as treatment and cures for diseases across a broad range of therapeutic areas; and they have an industry-leading pipeline of promising new products that have the potential to challenge some of the most feared diseases of their time, like Alzheimer's disease and cancer.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

1

—

Pfizer has raised a total of — in funding over 2 rounds. Their latest funding was raised on Jan 13, 1978 from a IPO round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Jan 13, 1978	IPO	—	—	—	—	Detail

Investments

Number of Investments

Number of Lead Investments

44

19

Pfizer has made 44 investments. Their most recent investment was on Dec 21, 2022, when ORIC Pharmaceuticals raised $25M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Dec 21, 2022 ORIC Pharmaceuticals	Post-IPO Equity	$25M	Biotechnology	Yes
Dec 1, 2022 Carrick Therapeutics	Series C	$60M	Biotechnology	Yes
Sep 20, 2022 CytoReason	Corporate Round	$20M	Biopharma	Yes
Jun 20, 2022 Valneva	Post-IPO Equity	€90.50M	Biotechnology	Yes
Jun 14, 2022 Dren Bio	Series B	$65M	Biotechnology	—

Employee Profiles

Number of Employee Profiles

144

Pfizer has 144 current employee profiles, including Board member Shantanu Narayen

Board member

Board member

Executive

Executive

Executive

Exits

Pfizer has had 18 exits. Pfizer most notable exits include LianBio , Sema4

Date	Company Name	Exit Type	Industry
Nov 1, 2021	LianBio	IPO	Biopharma	Detail
Jul 23, 2021	Sema4	IPO	Artificial Intelligence	Detail
May 6, 2021	Valneva	IPO	Biotechnology	Detail
Apr 28, 2021	Amplyx Pharmaceuticals	M&A	Biotechnology	Detail
Oct 28, 2020	Cerevel Therapeutics	IPO	Biotechnology	Detail

Acquisition

Pfizer has acquired 38 organizations. Their most recent acquisition was Warner-Lambert on Feb 7, 2000. They acquired Warner-Lambert for $90B.

Date Company Name	Industry	Acquisition Type	Price
Feb 7, 2000 Warner-Lambert	Biotechnology	acquisition	$ 90B	Detail
Jul 15, 2002 Pharmacia	Biotechnology	—	—	Detail
Dec 21, 2003 Esperion	Biotechnology	acquisition	$ 1.30B	Detail
Jan 21, 2005 Angiosyn	Biotechnology	acquisition	—	Detail
Feb 24, 2005 Idun Pharmaceuticals	Biopharma	acquisition	—	Detail